Total Payments
$40,181
2024 Payments
$51.84
Companies
13
Transactions
31
Medicare Patients
510
Medicare Billing
$54,393
Payment Breakdown by Category
Consulting$34,504 (85.9%)
Other$3,600 (9.0%)
Travel$1,277 (3.2%)
Food & Beverage$781.68 (1.9%)
Education$19.03 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $34,504 | 11 | 85.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,600 | 1 | 9.0% |
| Travel and Lodging | $1,277 | 5 | 3.2% |
| Food and Beverage | $781.68 | 12 | 1.9% |
| Education | $19.03 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $12,359 | 5 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $6,766 | 5 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $6,689 | 5 | $0 (2022) |
| PFIZER INC. | $3,608 | 2 | $0 (2022) |
| Blue Earth Diagnostics Limited | $2,646 | 4 | $0 (2018) |
| EISAI INC. | $2,625 | 2 | $0 (2019) |
| Immunomedics, Inc. | $2,363 | 1 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $2,261 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $671.25 | 1 | $0 (2019) |
| Roche Diagnostics Corporation | $108.19 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $51.84 | 1 | Verity Pharmaceuticals Inc. ($51.84) |
| 2023 | $7,459 | 4 | Gilead Sciences, Inc. ($7,459) |
| 2022 | $8,088 | 3 | Gilead Sciences, Inc. ($4,900) |
| 2021 | $5,861 | 3 | PFIZER INC. ($3,600) |
| 2020 | $5,871 | 5 | E.R. Squibb & Sons, L.L.C. ($3,509) |
| 2019 | $3,296 | 3 | EISAI INC. ($2,625) |
| 2018 | $2,659 | 5 | Blue Earth Diagnostics Limited ($2,646) |
| 2017 | $6,895 | 7 | Novartis Pharmaceuticals Corporation ($6,766) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $51.84 | General |
| Category: Prostate cancer | ||||||
| 11/29/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Consulting Fee | Cash or cash equivalent | $2,390.00 | General |
| Category: ONC | ||||||
| 11/17/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $41.54 | General |
| Category: ONC | ||||||
| 06/14/2023 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| 06/02/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $127.55 | General |
| 09/14/2022 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,900.00 | General |
| 08/01/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $3,180.00 | General |
| 04/08/2022 | PFIZER INC. | INLYTA (Drug) | Education | In-kind items and services | $8.16 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2021 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Education | In-kind items and services | $10.87 | General |
| Category: ONCOLOGY | ||||||
| 09/17/2021 | PFIZER INC. | XTANDI (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,600.00 | General |
| Category: ONCOLOGY | ||||||
| 03/26/2021 | Merck Sharp & Dohme Corporation | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 12/10/2020 | Immunomedics, Inc. | Trodelvy (Drug) | Consulting Fee | Cash or cash equivalent | $2,362.50 | General |
| Category: Oncology | ||||||
| 02/11/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Travel and Lodging | Cash or cash equivalent | $68.20 | General |
| Category: Oncology | ||||||
| 02/11/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $7.70 | General |
| Category: Oncology | ||||||
| 02/10/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Consulting Fee | Cash or cash equivalent | $3,420.00 | General |
| Category: Oncology | ||||||
| 01/29/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.04 | General |
| Category: Oncology | ||||||
| 08/22/2019 | EISAI INC. | Lenvima (Drug) | Consulting Fee | Cash or cash equivalent | $2,500.00 | General |
| Category: Oncology | ||||||
| 08/22/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Oncology | ||||||
| 01/15/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Consulting Fee | Cash or cash equivalent | $671.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2018 | Blue Earth Diagnostics Limited | Axumin (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Diagnostic Imaging | ||||||
| 03/15/2018 | Blue Earth Diagnostics Limited | Axumin (Drug) | Travel and Lodging | In-kind items and services | $499.00 | General |
| Category: Diagnostic Imaging | ||||||
| 03/15/2018 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Diagnostic Imaging | ||||||
| 03/01/2018 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $134.40 | General |
| Category: Diagnostic Imaging | ||||||
| 02/22/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Oncology | ||||||
| 12/02/2017 | Siemens Medical Solutions USA, Inc. | IMMULITE Immunoassay Reagents/Test Kit/Clinical Utilization (Device) | Food and Beverage | In-kind items and services | $21.20 | General |
| Category: DX - Diagnostics incl. all products and services | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 94 | 135 | $57,419 | $9,000 |
| 2022 | 4 | 124 | 223 | $89,584 | $16,239 |
| 2021 | 3 | 158 | 225 | $86,421 | $16,547 |
| 2020 | 2 | 134 | 183 | $71,724 | $12,606 |
Total Patients
510
Total Services
766
Medicare Billing
$54,393
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 53 | 86 | $38,564 | $6,203 | 16.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 36 | $11,220 | $1,711 | 15.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 13 | 13 | $7,635 | $1,087 | 14.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 59 | 133 | $55,720 | $10,119 | 18.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 63 | $18,591 | $3,058 | 16.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $7,638 | $1,531 | 20.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 13 | 13 | $7,635 | $1,531 | 20.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 53 | 85 | $33,375 | $6,525 | 19.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 63 | $23,045 | $4,429 | 19.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 33 | 44 | $11,848 | $2,181 | 18.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 19 | 19 | $10,411 | $2,092 | 20.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $7,742 | $1,321 | 17.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 97 | 146 | $51,743 | $8,672 | 16.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 37 | 37 | $19,981 | $3,934 | 19.7% |
About Bradley Carthon, MD, PHD
Bradley Carthon, MD, PHD is a Hematology & Oncology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/03/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700907276.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Bradley Carthon, MD, PHD has received a total of $40,181 in payments from pharmaceutical and medical device companies, with $51.84 received in 2024. These payments were reported across 31 transactions from 13 companies. The most common payment nature is "Consulting Fee" ($34,504).
As a Medicare-enrolled provider, Carthon has provided services to 510 Medicare beneficiaries, totaling 766 services with total Medicare billing of $54,393. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Internal Medicine, Medical Oncology
- Location Atlanta, GA
- Active Since 04/03/2007
- Last Updated 08/01/2011
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1700907276
Products in Payments
- VOTRIENT (Drug) $6,330
- Trodelvy (Drug) $4,794
- XTANDI (Drug) $3,600
- OPDIVO (Biological) $3,509
- Axumin (Drug) $2,646
- Lenvima (Drug) $2,625
- IMFINZI (Drug) $671.25
- AFINITOR (Drug) $436.00
- RS Harmony Test Related Products (Device) $108.19
- Trelstar (Drug) $51.84
- IMMULITE Immunoassay Reagents/Test Kit/Clinical Utilization (Device) $21.20
- ADCETRIS (Biological) $13.14
- KEYTRUDA (Biological) $10.87
- INLYTA (Drug) $8.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Atlanta
Dr. Jonathon Cohen, M.d, M.D
Hematology & Oncology — Payments: $330,523
Hematology & Oncology $330,523
Dr. Ajay Nooka, M.d., M.p.h.,F.a.c.p, M.D., M.P.H.,F.A.C.P
Hematology & Oncology — Payments: $256,358
Hematology & Oncology $256,358
Dr. Rodolfo Bordoni, Md, MD
Hematology & Oncology — Payments: $240,507
Hematology & Oncology $240,507
Dr. Mehmet Bilen, M.d, M.D
Hematology & Oncology — Payments: $134,196
Hematology & Oncology $134,196
Olatunji Alese, M.d, M.D
Hematology & Oncology — Payments: $131,083
Hematology & Oncology $131,083
Dr. Carlos Franco, Md, MD
Hematology & Oncology — Payments: $115,439
Hematology & Oncology $115,439